Fidelity Disruptive Medicine ETF
FMEDNASDAQFidelityEquity
As of Oct 16, 2026 close
- Assets (AUM)
- $51.42M
- Expense ratio
- 0.50%
- Dividend yield
- -
- Holdings
- 77
- 52-week range
- $23.48$32.99
- Volume (live)
- -
- Avg. volume (3M)
- 8.22K
FMED ETF: Fidelity Disruptive Medicine ETF - Price, Holdings & Analysis
Fidelity Disruptive Medicine ETF Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fund characteristics, expense ratio, dividend yield, and performance metrics
| Day's Range | $30.20 - $31.26 |
|---|---|
| 52-Week High | $32.99 |
| 52-Week Low | $23.48 |
| Open | $31.26 |
| Volume (last close) | 17.55K |
| Average Volume (3M) | 8.22K |
| 1 Day Change | +2.21% |
|---|---|
| 1 Month Change | −2.41% |
| 6 Month Change | +19.61% |
| YTD Change | +16.48% |
| 1 Year Change | +20.14% |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Last Dividend Ex-Date | Dec 20, 2024 |
| Dividend Growth YoY | −100.00% |
| Assets (AUM) | $51.42M |
|---|---|
| Expense Ratio | 0.50% |
| Total Holdings | 77 |
| Inception Date | Apr 15, 2020 |
| 50-Day MA | $31.42 |
|---|---|
| 200-Day MA | $27.51 |
| RSI | 43.28 |
| Stochastic %K | 22.83 |
| Stochastic %D | 25.67 |
Source: Exchange price data and fund disclosures. Data as of Oct 16, 2026. Data sources and methodology
FMED at a Glance
Fidelity Disruptive Medicine ETF (FMED) is an equity ETF from Fidelity, launched in April 2020. It manages $51.42M in assets and charges a 0.50% expense ratio, about $50 a year per $10,000 invested.
As of its Oct 4, 2026 holdings, it holds 77 positions. The largest are 10x Genomics, Inc. (TXG, 6.09%), Natera, Inc. (NTRA, 4.47%) and Thermo Fisher Scientific Inc. (TMO, 4.08%). The top 10 holdings make up 36.3% of the fund. By sector it leans toward Healthcare (100.0%). Its largest country exposures are United States (89.6%), Belgium (3.8%) and Switzerland (1.4%).
It does not currently pay distributions. As of the Oct 16, 2026 close, the share price is up 20.1% over one year (price change, excluding distributions).
Frequently Asked Questions About Fidelity Disruptive Medicine ETF
What is the current price of FMED?
The latest FMED price is $30.26 (Oct 16, 2026 close). The 52-week range is $23.48–$32.98. The share price is up 20.1% over the past year (price change, excluding distributions).
What is the expense ratio for FMED?
FMED's annual expense ratio is 0.50%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equity ETFs in the ETF Screener.
Does FMED pay dividends?
Fidelity Disruptive Medicine ETF does not currently pay dividends. Check the ETF Screener for dividend-focused alternatives in the Equity category.
What are the top holdings of FMED?
As of Oct 4, 2026, FMED's largest holdings are 10x Genomics, Inc. (6.1%), Natera, Inc. (4.5%), Thermo Fisher Scientific Inc. (4.1%) (combined weight: 14.6%). The fund holds 77 total positions. View the complete portfolio breakdown in the Holdings section.
How does FMED compare to similar ETFs?
Compare FMED (0.50% expense ratio, $51M AUM) against similar Equity ETFs using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.